Regulatory Experience

Programs & Measures Supported

Chart Abstracted Measures

  • Hospital Inpatient Quality Reporting (IQR) Program

    Stroke (STK) Measures

    • STK-1 Venous Thromboembolism Prophylaxis — Introduced 2012

    • STK-2 Discharged on Antithrombotic Therapy — Introduced 2012

    • STK-3 Anticoagulation Therapy for AFib/Flutter — Introduced 2012

    • STK-4 Thrombolytic Therapy — Introduced 2012

    • STK-5 Antithrombotic Therapy by End of Hospital Day 2 — Introduced 2012

    • STK-6 Discharged on Statin Medication — Introduced 2012

    • STK-8 Stroke Education — Introduced 2012

    • STK-10 Assessed for Rehabilitation — Introduced 2012

    Venous Thromboembolism (VTE) Measures

    • VTE-1 VTE Prophylaxis — Introduced 2011

    • VTE-2 ICU VTE Prophylaxis — Introduced 2011

    • VTE-3 VTE Patients with Anticoagulation Overlap Therapy — Introduced 2011

    • VTE-4 VTE Patients Receiving Unfractionated Heparin — Introduced 2011

    • VTE-5 VTE Warfarin Therapy Discharge Instructions — Introduced 2011

    • VTE-6 Hospital Acquired Potentially Preventable VTE — Introduced 2011

    Perinatal Care (PC) Measures

    • PC-01 Elective Delivery — Introduced 2012, Retired 2021

    • PC-02 Cesarean Birth — Introduced 2012

    • PC-03 Antenatal Steroids — Introduced 2012

    • PC-04 Health Care Associated Bloodstream Infections in Newborns — Introduced 2012, Retired 2018

    • PC-05 Exclusive Breast Milk Feeding — Introduced 2012

    Emergency Department (ED) Measures

    • ED-1 Median Time from ED Arrival to ED Departure for Admitted Patients — Introduced 2012, Retired 2015

    • ED-2 Admit Decision Time to ED Departure for Admitted Patients — Introduced 2012, Retired 2015

    Substance Use (SUB) Measures

    • SUB-1 Alcohol Use Screening — Introduced 2014

    • SUB-2 Alcohol Use Brief Intervention — Introduced 2014

    • SUB-2a Alcohol Use Brief Intervention Provided or Offered — Introduced 2014

    • SUB-3 Alcohol and Other Drug Use Disorder Treatment Provided or Offered — Introduced 2014

    • SUB-3a Alcohol and Other Drug Use Disorder Treatment — Introduced 2014

    Tobacco Treatment (TOB) Measures

    • TOB-1 Tobacco Use Screening — Introduced 2014

    • TOB-2 Tobacco Use Treatment Provided or Offered — Introduced 2014

    • TOB-2a Tobacco Use Treatment — Introduced 2014

    • TOB-3 Tobacco Use Treatment Provided or Offered at Discharge — Introduced 2014

    • TOB-3a Tobacco Use Treatment at Discharge — Introduced 2014

    Sepsis Measures

    • SEP-1 Early Management Bundle Severe Sepsis/Septic Shock — Introduced 2015

    Immunization Measures

    • IMM-2 Influenza Immunization — Introduced 2012, replaced IMM-1 which Retired 2013

    Surgical Care Improvement Project (SCIP) Measures

    • SCIP-Inf-1 Prophylactic Antibiotic Received Within 1 Hour — Retired 2015

    • SCIP-Inf-2 Prophylactic Antibiotic Selection — Retired 2015

    • SCIP-Inf-3 Prophylactic Antibiotics Discontinued Within 24 Hours — Retired 2015

    • SCIP-Inf-4 Cardiac Surgery Patients with Controlled Postoperative Blood Glucose — Retired 2015

    • SCIP-Inf-9 Urinary Catheter Removed on Postoperative Day 1 or 2 — Retired 2015

    • SCIP-Card-2 Surgery Patients on Beta-Blocker Therapy — Retired 2015

    • SCIP-VTE-1 Surgery Patients with Recommended VTE Prophylaxis Ordered — Retired 2015

    • SCIP-VTE-2 Surgery Patients Who Received Appropriate VTE Prophylaxis — Retired 2015

    Heart Failure (HF) Measures

    • HF-1 Discharge Instructions — Retired 2014

    • HF-2 Evaluation of LVS Function — Retired 2014

    • HF-3 ACEI or ARB for LVSD — Retired 2014

    Acute Myocardial Infarction (AMI) Measures

    • AMI-1 Aspirin at Arrival — Retired 2014

    • AMI-2 Aspirin Prescribed at Discharge — Retired 2014

    • AMI-3 ACEI or ARB for LVSD — Retired 2014

    • AMI-4 Adult Smoking Cessation Advice — Retired 2014

    • AMI-5 Beta-Blocker Prescribed at Discharge — Retired 2014

    • AMI-7a Fibrinolytic Therapy Received Within 30 Minutes — Retired 2014

    • AMI-8a Primary PCI Received Within 90 Minutes — Retired 2014

    Pneumonia (PN) Measures

    • PN-3b Blood Cultures Performed Before First Antibiotic — Retired 2013

    • PN-6 Initial Antibiotic Selection — Retired 2013

    Hospital Outpatient Quality Reporting (OQR) Program

    • OP-1 Median Time to Fibrinolysis — Retired 2017

    • OP-2 Fibrinolytic Therapy Received Within 30 Minutes — Retired 2017

    • OP-3 Median Time to Transfer to Another Facility — Retired 2017

    • OP-4 Aspirin at Arrival — Retired 2015

    • OP-5 Median Time to ECG — Retired 2017

    • OP-18 Median Time from ED Arrival to ED Departure — Introduced 2012

    • OP-19 Transition Record with Specified Elements — Introduced 2012, Retired 2016

    • OP-20 Door to Diagnostic Evaluation — Introduced 2012

    • OP-21 ED-Median Time to Pain Management — Introduced 2012, Retired 2018

    • OP-22 Left Without Being Seen — Introduced 2012, Retired 2018

    • OP-23 Head CT Scan Results — Introduced 2013, Retired 2018

    Inpatient Psychiatric Facility Quality Reporting (IPFQR) Program

    • HBIPS-1 Physical Restraint Use — Introduced 2013, Retired 2018

    • HBIPS-2 Hours of Physical Restraint Use — Introduced 2013

    • HBIPS-3 Hours of Seclusion Use — Introduced 2013

    • HBIPS-4 Patients Discharged on Multiple Antipsychotic Medications — Introduced 2013, Retired 2018

    • HBIPS-5 Patients Discharged on Multiple Antipsychotic Medications with Appropriate Justification — Introduced 2013

    • HBIPS-6 Post Discharge Continuing Care Plan Created — Introduced 2013, Retired 2018

    • HBIPS-7 Post Discharge Continuing Care Plan Transmitted — Introduced 2013, Retired 2018

    • TOB-1 Tobacco Use Screening — Introduced 2014

    • TOB-2 Tobacco Use Treatment — Introduced 2014

    • TOB-3 Tobacco Use Treatment at Discharge — Introduced 2014

    • SUB-1 Alcohol Use Screening — Introduced 2014

    • SUB-2 Alcohol Use Brief Intervention — Introduced 2014

    • SUB-3 Alcohol and Other Drug Use Disorder Treatment — Introduced 2014

    • FUH Follow-Up After Hospitalization for Mental Illness — Introduced 2016

    • IMM-2 Influenza Immunization — Introduced 2016

  • ORYX Performance Measurement Program

    Acute Myocardial Infarction (AMI) Measures

    • AMI-1 Aspirin at Arrival — Retired 2014

    • AMI-2 Aspirin Prescribed at Discharge — Retired 2014

    • AMI-3 ACEI or ARB for LVSD — Retired 2014

    • AMI-4 Adult Smoking Cessation Advice — Retired 2014

    • AMI-5 Beta-Blocker Prescribed at Discharge — Retired 2014

    • AMI-7a Fibrinolytic Therapy Received Within 30 Minutes — Retired 2014

    • AMI-8a Primary PCI Received Within 90 Minutes — Retired 2014

    Heart Failure (HF) Measures

    • HF-1 Discharge Instructions — Retired 2014

    • HF-2 Evaluation of LVS Function — Retired 2014

    • HF-3 ACEI or ARB for LVSD — Retired 2014

    • HF-4 Adult Smoking Cessation Advice — Retired 2014

    Pneumonia (PN) Measures

    • PN-3b Blood Cultures Performed Before First Antibiotic — Retired 2013

    • PN-6 Initial Antibiotic Selection — Retired 2013

    Surgical Care Improvement Project (SCIP) Measures

    • SCIP-Inf-1 Prophylactic Antibiotic Received Within 1 Hour — Retired 2015

    • SCIP-Inf-2 Prophylactic Antibiotic Selection — Retired 2015

    • SCIP-Inf-3 Prophylactic Antibiotics Discontinued Within 24 Hours — Retired 2015

    • SCIP-Inf-4 Cardiac Surgery Patients with Controlled Postoperative Blood Glucose — Retired 2015

    • SCIP-Inf-9 Urinary Catheter Removed on Postoperative Day 1 or 2 — Retired 2015

    • SCIP-Card-2 Surgery Patients on Beta-Blocker Therapy — Retired 2015

    • SCIP-VTE-1 Surgery Patients with Recommended VTE Prophylaxis Ordered — Retired 2015

    • SCIP-VTE-2 Surgery Patients Who Received Appropriate VTE Prophylaxis — Retired 2015

    Stroke (STK) Measures

    • STK-1 Venous Thromboembolism Prophylaxis — Introduced 2012

    • STK-2 Discharged on Antithrombotic Therapy — Introduced 2012

    • STK-3 Anticoagulation Therapy for AFib/Flutter — Introduced 2012

    • STK-4 Thrombolytic Therapy — Introduced 2012

    • STK-5 Antithrombotic Therapy by End of Hospital Day 2 — Introduced 2012

    • STK-6 Discharged on Statin Medication — Introduced 2012

    • STK-8 Stroke Education — Introduced 2012

    • STK-10 Assessed for Rehabilitation — Introduced 2012

    Venous Thromboembolism (VTE) Measures

    • VTE-1 VTE Prophylaxis — Introduced 2011

    • VTE-2 ICU VTE Prophylaxis — Introduced 2011

    • VTE-3 VTE Patients with Anticoagulation Overlap Therapy — Introduced 2011

    • VTE-4 VTE Patients Receiving Unfractionated Heparin — Introduced 2011

    • VTE-5 VTE Warfarin Therapy Discharge Instructions — Introduced 2011

    • VTE-6 Hospital Acquired Potentially Preventable VTE — Introduced 2011

    Perinatal Care (PC) Measures

    • PC-01 Elective Delivery — Introduced 2012, Retired 2021

    • PC-02 Cesarean Birth — Introduced 2012

    • PC-03 Antenatal Steroids — Introduced 2012

    • PC-04 Health Care Associated Bloodstream Infections in Newborns — Introduced 2012, Retired 2018

    • PC-05 Exclusive Breast Milk Feeding — Introduced 2012

    • PC-06 Unexpected Complications in Term Newborns — Introduced 2014

    Substance Use (SUB) Measures

    • SUB-1 Alcohol Use Screening — Introduced 2014

    • SUB-2 Alcohol Use Brief Intervention — Introduced 2014

    • SUB-2a Alcohol Use Brief Intervention Provided or Offered — Introduced 2014

    • SUB-3 Alcohol and Other Drug Use Disorder Treatment Provided or Offered — Introduced 2014

    • SUB-3a Alcohol and Other Drug Use Disorder Treatment — Introduced 2014

    Tobacco Treatment (TOB) Measures

    • TOB-1 Tobacco Use Screening — Introduced 2014

    • TOB-2 Tobacco Use Treatment Provided or Offered — Introduced 2014

    • TOB-2a Tobacco Use Treatment — Introduced 2014

    • TOB-3 Tobacco Use Treatment Provided or Offered at Discharge — Introduced 2014

    • TOB-3a Tobacco Use Treatment at Discharge — Introduced 2014

    Immunization Measures

    • IMM-1 Influenza Immunization — Retired 2013

    • IMM-2 Pneumococcal Vaccination — Introduced 2012

    Sepsis Measures

    • SEP-1 Early Management Bundle Severe Sepsis/Septic Shock — Introduced 2015

    Behavioral Health Care (BHC) Measures

    • HBIPS-1 Physical Restraint Use — Introduced 2013, Retired 2018

    • HBIPS-2 Hours of Physical Restraint Use — Introduced 2013

    • HBIPS-3 Hours of Seclusion Use — Introduced 2013

    • HBIPS-4 Patients Discharged on Multiple Antipsychotic Medications — Introduced 2013, Retired 2018

    • HBIPS-5 Patients Discharged on Multiple Antipsychotic Medications with Appropriate Justification — Introduced 2013

    • HBIPS-6 Post Discharge Continuing Care Plan Created — Introduced 2013, Retired 2018

    • HBIPS-7 Post Discharge Continuing Care Plan Transmitted — Introduced 2013, Retired 2018

    • TOB-1 Tobacco Use Screening — Introduced 2014

    • TOB-2 Tobacco Use Treatment — Introduced 2014

    • TOB-3 Tobacco Use Treatment at Discharge — Introduced 2014

    • SUB-1 Alcohol Use Screening — Introduced 2014

    • SUB-2 Alcohol Use Brief Intervention — Introduced 2014

    • SUB-3 Alcohol and Other Drug Use Disorder Treatment — Introduced 2014

    • FUH Follow-Up After Hospitalization for Mental Illness — Introduced 2016

    • IMM-2 Influenza Immunization — Introduced 2016

  • CMS Critical Access Hospital Quality Reporting (CAHQR) Program

    Outpatient Measures (OP)

    • OP-1 Median Time to Fibrinolysis — Retired 2017

    • OP-2 Fibrinolytic Therapy Received Within 30 Minutes — Retired 2017

    • OP-3 Median Time to Transfer to Another Facility — Retired 2017

    • OP-4 Aspirin at Arrival — Retired 2015

    • OP-5 Median Time to ECG — Retired 2017

    • OP-18 Median Time from ED Arrival to ED Departure — Introduced 2012

    • OP-20 Door to Diagnostic Evaluation — Introduced 2012

    • OP-21 ED Median Time to Pain Management — Introduced 2012, Retired 2018

    • OP-22 Left Without Being Seen — Introduced 2012, Retired 2018

    • OP-23 Head CT Scan Results — Introduced 2013, Retired 2018

    Inpatient Measures

    Acute Myocardial Infarction (AMI) Measures

    • AMI-1 Aspirin at Arrival — Retired 2014

    • AMI-2 Aspirin Prescribed at Discharge — Retired 2014

    • AMI-3 ACEI or ARB for LVSD — Retired 2014

    • AMI-4 Adult Smoking Cessation Advice — Retired 2014

    • AMI-5 Beta-Blocker Prescribed at Discharge — Retired 2014

    • AMI-7a Fibrinolytic Therapy Received Within 30 Minutes — Retired 2014

    • AMI-8a Primary PCI Received Within 90 Minutes — Retired 2014

    Heart Failure (HF) Measures

    • HF-1 Discharge Instructions — Retired 2014

    • HF-2 Evaluation of LVS Function — Retired 2014

    • HF-3 ACEI or ARB for LVSD — Retired 2014

    • HF-4 Adult Smoking Cessation Advice — Retired 2014

    Pneumonia (PN) Measures

    • PN-3b Blood Cultures Performed Before First Antibiotic — Retired 2013

    • PN-6 Initial Antibiotic Selection — Retired 2013

    Surgical Care Improvement Project (SCIP) Measures

    • SCIP-Inf-1 Prophylactic Antibiotic Received Within 1 Hour — Retired 2015

    • SCIP-Inf-2 Prophylactic Antibiotic Selection — Retired 2015

    • SCIP-Inf-3 Prophylactic Antibiotics Discontinued Within 24 Hours — Retired 2015

    • SCIP-Inf-4 Cardiac Surgery Patients with Controlled Postoperative Blood Glucose — Retired 2015

    • SCIP-Inf-9 Urinary Catheter Removed on Postoperative Day 1 or 2 — Retired 2015

    • SCIP-Card-2 Surgery Patients on Beta-Blocker Therapy — Retired 2015

    • SCIP-VTE-1 Surgery Patients with Recommended VTE Prophylaxis Ordered — Retired 2015

    • SCIP-VTE-2 Surgery Patients Who Received Appropriate VTE Prophylaxis — Retired 2015

    Stroke (STK) Measures

    • STK-1 Venous Thromboembolism Prophylaxis — Introduced 2012

    • STK-2 Discharged on Antithrombotic Therapy — Introduced 2012

    • STK-3 Anticoagulation Therapy for AFib/Flutter — Introduced 2012

    • STK-4 Thrombolytic Therapy — Introduced 2012

    • STK-5 Antithrombotic Therapy by End of Hospital Day 2 — Introduced 2012

    • STK-6 Discharged on Statin Medication — Introduced 2012

    • STK-8 Stroke Education — Introduced 2012

    • STK-10 Assessed for Rehabilitation — Introduced 2012

    Venous Thromboembolism (VTE) Measures

    • VTE-1 VTE Prophylaxis — Introduced 2011

    • VTE-2 ICU VTE Prophylaxis — Introduced 2011

    • VTE-3 VTE Patients with Anticoagulation Overlap Therapy — Introduced 2011

    • VTE-4 VTE Patients Receiving Unfractionated Heparin — Introduced 2011

    • VTE-5 VTE Warfarin Therapy Discharge Instructions — Introduced 2011

    • VTE-6 Hospital Acquired Potentially Preventable VTE — Introduced 2011

    Perinatal Care (PC) Measures

    • PC-01 Elective Delivery — Introduced 2012, Retired 2021

    • PC-02 Cesarean Birth — Introduced 2012

    • PC-03 Antenatal Steroids — Introduced 2012

    • PC-04 Health Care Associated Bloodstream Infections in Newborns — Introduced 2012, Retired 2018

    • PC-05 Exclusive Breast Milk Feeding — Introduced 2012

    Substance Use (SUB) Measures

    • SUB-1 Alcohol Use Screening — Introduced 2014

    • SUB-2 Alcohol Use Brief Intervention — Introduced 2014

    • SUB-2a Alcohol Use Brief Intervention Provided or Offered — Introduced 2014

    • SUB-3 Alcohol and Other Drug Use Disorder Treatment Provided or Offered — Introduced 2014

    • SUB-3a Alcohol and Other Drug Use Disorder Treatment — Introduced 2014

    Tobacco Treatment (TOB) Measures

    • TOB-1 Tobacco Use Screening — Introduced 2014

    • TOB-2 Tobacco Use Treatment Provided or Offered — Introduced 2014

    • TOB-2a Tobacco Use Treatment — Introduced 2014

    • TOB-3 Tobacco Use Treatment Provided or Offered at Discharge — Introduced 2014

    • TOB-3a Tobacco Use Treatment at Discharge — Introduced 2014

    Sepsis Measures

    • SEP-1 Early Management Bundle Severe Sepsis/Septic Shock — Introduced 2015

    Immunization Measures

    • IMM-1 Influenza Immunization — Retired 2013

    • IMM-2 Influenza Immunization — Introduced 2012

  • Software Used

    • eQualityCheck to abstract patients data

    • SAP Business Objects to view reports

    • Submission in portals to reporting agencies via browser or CSV

  • Agencies

    • CMS

    • TJC

    • State Agencies

Electronic Measures

  • Programs

    Meaningful Use (MU)

    • Stage 1 (2011-2012) — Data Capture and Sharing

      • CQMs- Clinical Quality Measures

      Stage 2 (2014) — Advance Clinical Processes

      • Electronic submission of clinical quality measures (eCQMs)

      Stage 3 (2016 forward) — Improved Outcomes

      • Clinical decision support for high-priority conditions

      • Computerized provider order entry (CPOE)

      • Electronic submission of clinical quality measures (eCQMs)

      Promoting Interoperability (PI)

      • Submit data based on the CMS required reporting period.

      • Report data using the ONC Health IT certification criteria to meet the CEHRT requirement.

      • Report data using CMS approved CY 2025 measure specifications.

      • Successfully submit data to the HQR Secure Portal by the submission deadline:

      EHR Incentive Programs

      • Medicare EHR Incentive Program — incentive payments to eligible professionals and hospitals for demonstrating meaningful use

      • Medicaid EHR Incentive Program — separately administered by states, offered incentives for adoption and meaningful use

      • Eligible Professionals (EPs) — physicians and other qualified clinicians

      • Eligible Hospitals (EHs) — acute care hospitals and critical access hospitals

      • Critical Access Hospitals (CAHs) — separate reporting requirements and payment methodology

  • Software Used

    • Cerner Millennium Suite for Data Capture

    • SAP Business Objects to View Reports

    • Submission in portals to reporting agencies via browser or CSV

  • Agencies

    • CMS

    • TJC

    • State Agencies